Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 2
1961 1
1964 1
1967 1
1970 1
1971 2
1977 3
1978 2
1979 1
1982 2
1991 1
1992 3
1993 2
1994 2
2003 2
2004 3
2005 8
2006 6
2007 2
2008 9
2009 5
2010 4
2011 9
2012 5
2013 5
2014 5
2015 12
2016 8
2017 5
2018 2
2019 6
2020 6
2021 7
2022 8
2023 7
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

140 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of remibrutinib, a selective potent oral BTK inhibitor, in Sjögren's syndrome: results from a randomised, double-blind, placebo-controlled phase 2 trial.
Dörner T, Kaul M, Szántó A, Tseng JC, Papas AS, Pylvaenaeinen I, Hanser M, Abdallah N, Grioni A, Santos Da Costa A, Ferrero E, Gergely P, Hillenbrand R, Avrameas A, Cenni B, Siegel RM. Dörner T, et al. Among authors: szanto a. Ann Rheum Dis. 2024 Feb 15;83(3):360-371. doi: 10.1136/ard-2023-224691. Ann Rheum Dis. 2024. PMID: 37932009 Free PMC article. Clinical Trial.
Mortality risk factors in primary Sjögren syndrome: a real-world, retrospective, cohort study.
Brito-Zerón P, Flores-Chávez A, Horváth IF, Rasmussen A, Li X, Olsson P, Vissink A, Priori R, Armagan B, Hernandez-Molina G, Praprotnik S, Quartuccio L, Inanç N, Özkızıltaş B, Bartoloni E, Sebastian A, Romão VC, Solans R, Pasoto SG, Rischmueller M, Galisteo C, Suzuki Y, Trevisani VFM, Fugmann C, González-García A, Carubbi F, Jurcut C, Shimizu T, Retamozo S, Atzeni F, Hofauer B, Melchor-Díaz S, Gheita T, López-Dupla M, Fonseca-Aizpuru E, Giacomelli R, Vázquez M, Consani S, Akasbi M, Nakamura H, Szántó A, Farris AD, Wang L, Mandl T, Gattamelata A, Kilic L, Pirkmajer KP, Abacar K, Tufan A, de Vita S, Bootsma H, Ramos-Casals M; Sjögren Big Data Consortium. Brito-Zerón P, et al. Among authors: szanto a. EClinicalMedicine. 2023 Jul 4;61:102062. doi: 10.1016/j.eclinm.2023.102062. eCollection 2023 Jul. EClinicalMedicine. 2023. PMID: 37457113 Free PMC article.
[Psychological features of primary Sjögren syndrome].
V Módis L, Szántó A, Bugán A. V Módis L, et al. Among authors: szanto a. Orv Hetil. 2021 Sep 26;162(39):1558-1566. doi: 10.1556/650.2021.32234. Orv Hetil. 2021. PMID: 34570718 Hungarian.
EZH2 inhibitor tazemetostat in patients with relapsed or refractory, BAP1-inactivated malignant pleural mesothelioma: a multicentre, open-label, phase 2 study.
Zauderer MG, Szlosarek PW, Le Moulec S, Popat S, Taylor P, Planchard D, Scherpereel A, Koczywas M, Forster M, Cameron RB, Peikert T, Argon EK, Michaud NR, Szanto A, Yang J, Chen Y, Kansra V, Agarwal S, Fennell DA. Zauderer MG, et al. Among authors: szanto a. Lancet Oncol. 2022 Jun;23(6):758-767. doi: 10.1016/S1470-2045(22)00277-7. Epub 2022 May 16. Lancet Oncol. 2022. PMID: 35588752 Clinical Trial.
Influence of exposure to climate-related hazards in the phenotypic expression of primary Sjögren's syndrome.
Flores-Chávez A, Brito-Zerón P, Ng WF, Szántó A, Rasmussen A, Priori R, Baldini C, Armagan B, Özkiziltaş B, Praprotnik S, Suzuki Y, Quartuccio L, Hernández-Molina G, Inanc N, Bartoloni E, Rischmueller M, Reis-de Oliveira F, Fernandes Moça Trevisani V, Jurcut C, Nordmark G, Carubbi F, Hofauer B, Valim V, Pasoto SG, Retamozo S, Atzeni F, Fonseca-Aizpuru E, López-Dupla M, Giacomelli R, Nakamura H, Akasbi M, Thompson K, Fanny Horváth I, Farris AD, Simoncelli E, Bombardieri S, Kilic L, Tufan A, Perdan Pirkmajer K, Fujisawa Y, De Vita S, Abacar K, Ramos-Casals M; Sjögren Big Data Consortium. Flores-Chávez A, et al. Among authors: szanto a. Clin Exp Rheumatol. 2023 Dec;41(12):2437-2447. doi: 10.55563/clinexprheumatol/pmbay6. Epub 2023 Nov 27. Clin Exp Rheumatol. 2023. PMID: 38019164 Free article.
Exposure to air pollution as an environmental determinant of how Sjögren's disease is expressed at diagnosis.
Brito-Zerón P, Flores-Chávez A, Ng WF, Fanny Horváth I, Rasmussen A, Priori R, Baldini C, Armagan B, Özkiziltaş B, Praprotnik S, Suzuki Y, Quartuccio L, Hernandez-Molina G, Abacar K, Bartoloni E, Rischmueller M, Reis-de Oliveira F, Fernandes Moça Trevisani V, Jurcut C, Fugmann C, Carubbi F, Hofauer B, Valim V, Pasoto SG, Retamozo S, Atzeni F, Fonseca-Aizpuru E, López-Dupla M, Giacomelli R, Nakamura H, Akasbi M, Thompson K, Szántó A, Farris AD, Villa M, Bombardieri S, Kilic L, Tufan A, Perdan Pirkmajer K, Fujisawa Y, de Vita S, Inanc N, Ramos-Casals M; Sjögren Big Data Consortium. Brito-Zerón P, et al. Among authors: szanto a. Clin Exp Rheumatol. 2023 Dec;41(12):2448-2457. doi: 10.55563/clinexprheumatol/p1r1j4. Epub 2023 Nov 29. Clin Exp Rheumatol. 2023. PMID: 38019154 Free article.
Characterization and outcomes of 414 patients with primary SS who developed haematological malignancies.
Hernández-Molina G, Kostov B, Brito-Zerón P, Vissink A, Mandl T, Hinrichs AC, Quartuccio L, Baldini C, Seror R, Szántó A, Isenberg D, Gerli R, Nordmark G, Rasmussen A, Solans-Laque R, Hofauer B, Sène D, Pasoto SG, Rischmueller M, Praprotnik S, Gheita TA, Danda D, Armağan B, Suzuki Y, Valim V, Devauchelle-Pensec V, Retamozo S, Kvarnstrom M, Sebastian A, Atzeni F, Giacomelli R, Carsons SE, Kwok SK, Nakamura H, Fernandes Moça Trevisani V, Flores-Chávez A, Mariette X, Ramos-Casals M; Sjögren Big Data Consortium. Hernández-Molina G, et al. Among authors: szanto a. Rheumatology (Oxford). 2022 Dec 23;62(1):243-255. doi: 10.1093/rheumatology/keac205. Rheumatology (Oxford). 2022. PMID: 35385104
140 results